The death this week of a teenager receiving Sarepta Therapeutics’ gene therapy Elevidys for Duchenne muscular dystrophy is a tragic reminder of the stakes involved in cutting-edge biotech ...

George Washington University, a private institution, has been offering online bachelor's degree programs since before 2000-2001. All of the online classes are recorded and archived so students can ...

The application deadline for the online MBA programs at George Washington University, a private school, is rolling. Ninety-one percent of students are already employed when they first enroll.

HighTower Advisors LLC’s holdings in Sarepta Therapeutics were worth $4,471,000 at the end of the most recent quarter. Other hedge funds also recently made changes to their positions in the company.

The company behind the drug, Sarepta Therapeutics, said that the patient suffered acute liver injury, a known side effect, The Associated Press reported. However, the “severity” of this case had not ...

Sarepta says more than 800 patients have received the treatment The company plans to update prescribing information after this case WEDNESDAY, March 19, 2025 (HealthDay News) -- A patient has died ...

A patient died from liver injury while taking the gene therapy Elevidys Sarepta says more than 800 patients have received the treatment The company plans to update prescribing information after ...

Sarepta says more than 800 patients have received the treatment The company plans to update prescribing information after this case WEDNESDAY, March 19, 2025 (HealthDay News) -- A patient has died ...

A patient has died while receiving Elevidys, a gene therapy for Duchenne muscular dystrophy, marking the first known death linked to the treatment. The company behind the drug, Sarepta ...

Sarepta Therapeutics has a 12-month low of $73.06 and a 12-month high of $173.25. The firm has a market capitalization of $7.14 billion, a price-to-earnings ratio of 58.83 and a beta of 0.79 ...